Orion Oyj
ORINY · OTC
Bulios Fair Price
$24.8
49.2% downside
Current Price
$48.79
According to Bulios Fair Price, ORINY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Orion Oyj is a Finnish pharmaceutical company headquartered in Espoo, focused on the research, development, manufacturing, and distribution of medicines and healthcare products. The company specializes in treatments for neurological and respiratory diseases, oncology, and urological disorders, while also offering a wide range of generic medicines and veterinary products. Orion operates not only in Finland but also internationally, in collaboration with various global partners. The company is recognized for its long-standing scientific heritage, high-quality standards, and strong focus on innovations that enhance patients’ quality of life.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Aino Anna Liisa Hurme
Employees
4,029
Headquarters
Espoo